Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
Matteo Bassetti, Antonio Vena, Chiara Sepulcri, et al.
Antibiotics (2020) Vol. 9, Iss. 9, pp. 632-632
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
George L. Daikos, Clóvis Arns da Cunha, Gian María Rossolini, et al.
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1126-1126
Open Access | Times Cited: 61
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
Matteo Bassetti, Alessandra Mularoni, Daniele Roberto Giacobbe, et al.
Seminars in Respiratory and Critical Care Medicine (2022) Vol. 43, Iss. 02, pp. 280-294
Open Access | Times Cited: 46
Pseudomonas aeruginosa Infections in Cancer Patients
Paulina Paprocka, Bonita Durnaś, Angelika Mańkowska, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 679-679
Open Access | Times Cited: 37
Early appropriate diagnostics and treatment of MDR Gram-negative infections
Matteo Bassetti, Souha S. Kanj, Pattarachai Kiratisin, et al.
JAC-Antimicrobial Resistance (2022) Vol. 4, Iss. 5
Open Access | Times Cited: 30
New antibiotics for Gram-negative pneumonia
Matteo Bassetti, Federica Magnè, Daniele Roberto Giacobbe, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220119-220119
Open Access | Times Cited: 29
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 7
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)
Hélio S. Sader, Rodrigo E. Mendes, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease (2021) Vol. 102, Iss. 1, pp. 115557-115557
Open Access | Times Cited: 32
Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of papiliocin, an insect innate immune response molecule
Manigandan Krishnan, Joonhyeok Choi, Ahjin Jang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 10
Open Access | Times Cited: 25
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
Nicola Coppola, Alberto Enrico Maraolo, Lorenzo Onorato, et al.
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1263-1263
Open Access | Times Cited: 23
Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations
Andrea Marıno, Stefano Stracquadanio, Edoardo Campanella, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 49-49
Open Access | Times Cited: 22
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients
Hélio S. Sader, Rodrigo E. Mendes, John H. Kimbrough, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 564-564
Open Access | Times Cited: 4
Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections
Μαρία Τσιλικά, Fotinie Ntziora, Efthymia Giannitsioti
Pathogens (2025) Vol. 14, Iss. 2, pp. 130-130
Open Access
The Impact of the COVID-19 Pandemic on the Antibiotic Resistance of Gram-Negative Pathogens Causing Bloodstream Infections in an Intensive Care Unit
Andreea Loredana Golli, Simona Georgiana Popa, Alice Elena Ghenea, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 379-379
Open Access
Prevalence of NDM-1 metallo-β-lactamase-producing Brevundimonas diminuta/vesicularis isolated from bloodstream infections in Iraq
Nadheema Hammood Hussein, Israa M.S. Al-Kadmy, Muthana Anad Majid, et al.
Reviews in Medical Microbiology (2025)
Closed Access
Multidrug-resistant hypervirulent Klebsiella pneumoniae : an evolving superbug
Yuzhong Zheng, Xiaojue Zhu, Chao Ding, et al.
Future Microbiology (2025), pp. 1-13
Closed Access
Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
Archives of Medical Research (2021) Vol. 52, Iss. 8, pp. 817-827
Closed Access | Times Cited: 30
Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis
Negar Narimisa, Forough Goodarzi, Shirin Bavari
Annals of Clinical Microbiology and Antimicrobials (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives
Matteo Bassetti, Nadia Castaldo, Alberto Fantin, et al.
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 6, pp. 615-622
Closed Access | Times Cited: 11
The Molecular Mouse System: A New Useful Tool for Guiding Antimicrobial Therapy in Critically Ill Septic Patients
Carola Mauri, Alessandra Consonni, Elena Briozzo, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 517-517
Open Access | Times Cited: 3
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates
Emanuela Roscetto, Rosa Bellavita, Rossella Paolillo, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1312-1312
Open Access | Times Cited: 20
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae
Alessandro Russo, Paolo Fusco, Helen Linda Morrone, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 21, Iss. 1, pp. 41-55
Closed Access | Times Cited: 14
Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety
Jian Qu, Tingting Qi, Qiang Qu, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 1205-1218
Open Access | Times Cited: 13
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents
Mariana Castanheira, John H. Kimbrough, Jill Lindley, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 5
Open Access | Times Cited: 2
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis
Ryan K. Shields, Juan Pablo Horcajada, Shweta Kamat, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 7, pp. 1639-1664
Open Access | Times Cited: 2
Green synthesis of N,S dual heteroatom-doped fluorescent carbon dots (N,S-CDs) and their applications in gentamicin sensing and dual-switch anti-counterfeiting encryption
Xiang Long, Hongxiang Liu, Jing Hu, et al.
Dyes and Pigments (2024) Vol. 231, pp. 112413-112413
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top